Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Pediatric Hematology
What are some of the medical management strategies for pediatric extracranial AVMs?
Related Questions
Is there any benefit to using desmopressin over vWF replacement therapy for vWD?
Does your evaluation of a young person with spontaneous upper extremity DVT vary as compared to lower extremity DVT?
What would you recommend for long term management of extensive dural venous sinus thrombosis (CVST) in young females when the only provoking risk factor is combined OCP?
How do you counsel sickle cell patients on the use of G-CSF to treat neutropenia from other causes, like malignancy?
Is there any indication for hydroxyurea in patients with sickle cell trait?
What is your diagnostic and treatment approach to pediatric patients with erythrocytosis?
In patients with lupus nephritis, and MAHA with positive anti-phospholipid autoantibodies, what are the considerations to use or not use anti-coagulation therapy?
How is your experience with point-of-care INR systems for home monitoring of vitamin K antagonists?
What is your strategy for optimizing hydroxyurea dosage in patients with symptomatic sickle cell disease, particularly for genotypes HbSS and HbS/Beta thal?
When do you consider testing with stroke gene panels in young stroke patients?
